• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床中的变异检测:基于生物学、临床和实验室变量做出明智的变异检测决策

Calling Variants in the Clinic: Informed Variant Calling Decisions Based on Biological, Clinical, and Laboratory Variables.

作者信息

Bohannan Zachary S, Mitrofanova Antonina

机构信息

Rutgers, The State University of New Jersey, School of Health Professions, Department of Health Informatics, 65 Bergen Street, Suite 120, Newark, NJ 07107-1709, United States of America.

出版信息

Comput Struct Biotechnol J. 2019 Apr 8;17:561-569. doi: 10.1016/j.csbj.2019.04.002. eCollection 2019.

DOI:10.1016/j.csbj.2019.04.002
PMID:31049166
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6482431/
Abstract

Deep sequencing genomic analysis is becoming increasingly common in clinical research and practice, enabling accurate identification of diagnostic, prognostic, and predictive determinants. Variant calling, distinguishing between true mutations and experimental errors, is a central task of genomic analysis and often requires sophisticated statistical, computational, and/or heuristic techniques. Although variant callers seek to overcome noise inherent in biological experiments, variant calling can be significantly affected by outside factors including those used to prepare, store, and analyze samples. The goal of this review is to discuss known experimental features, such as sample preparation, library preparation, and sequencing, alongside diverse biological and clinical variables, and evaluate their effect on variant caller selection and optimization.

摘要

深度测序基因组分析在临床研究和实践中越来越普遍,能够准确识别诊断、预后和预测决定因素。变异检测,即区分真正的突变和实验误差,是基因组分析的核心任务,通常需要复杂的统计、计算和/或启发式技术。尽管变异检测工具试图克服生物实验中固有的噪声,但变异检测可能会受到外部因素的显著影响,包括用于制备、储存和分析样本的因素。本综述的目的是讨论已知的实验特征,如样本制备、文库制备和测序,以及各种生物学和临床变量,并评估它们对变异检测工具选择和优化的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59bc/6482431/05a9ccbafd3e/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59bc/6482431/7b85886ebf0f/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59bc/6482431/48b5b35e3a6e/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59bc/6482431/37fe48e6e6c9/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59bc/6482431/05a9ccbafd3e/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59bc/6482431/7b85886ebf0f/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59bc/6482431/48b5b35e3a6e/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59bc/6482431/37fe48e6e6c9/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59bc/6482431/05a9ccbafd3e/gr3.jpg

相似文献

1
Calling Variants in the Clinic: Informed Variant Calling Decisions Based on Biological, Clinical, and Laboratory Variables.临床中的变异检测:基于生物学、临床和实验室变量做出明智的变异检测决策
Comput Struct Biotechnol J. 2019 Apr 8;17:561-569. doi: 10.1016/j.csbj.2019.04.002. eCollection 2019.
2
Leveraging Spatial Variation in Tumor Purity for Improved Somatic Variant Calling of Archival Tumor Only Samples.利用肿瘤纯度的空间变异改进仅存档肿瘤样本的体细胞变异检测
Front Oncol. 2019 Mar 20;9:119. doi: 10.3389/fonc.2019.00119. eCollection 2019.
3
Using genotype array data to compare multi- and single-sample variant calls and improve variant call sets from deep coverage whole-genome sequencing data.利用基因型阵列数据比较多样本和单样本变异检测结果,并改进来自深度覆盖全基因组测序数据的变异检测集。
Bioinformatics. 2017 Apr 15;33(8):1147-1153. doi: 10.1093/bioinformatics/btw786.
4
SNVSniffer: an integrated caller for germline and somatic single-nucleotide and indel mutations.SNVSniffer:一种用于种系和体细胞单核苷酸及插入缺失突变的综合检测工具。
BMC Syst Biol. 2016 Aug 1;10 Suppl 2(Suppl 2):47. doi: 10.1186/s12918-016-0300-5.
5
Best practices for evaluating single nucleotide variant calling methods for microbial genomics.评估微生物基因组学单核苷酸变异检测方法的最佳实践。
Front Genet. 2015 Jul 7;6:235. doi: 10.3389/fgene.2015.00235. eCollection 2015.
6
A hybrid computational strategy to address WGS variant analysis in >5000 samples.一种用于处理5000多个样本的全基因组测序(WGS)变异分析的混合计算策略。
BMC Bioinformatics. 2016 Sep 10;17(1):361. doi: 10.1186/s12859-016-1211-6.
7
Evaluation of Nine Somatic Variant Callers for Detection of Somatic Mutations in Exome and Targeted Deep Sequencing Data.评估九种体细胞变异检测工具在全外显子组测序和靶向深度测序数据中检测体细胞突变的性能
PLoS One. 2016 Mar 22;11(3):e0151664. doi: 10.1371/journal.pone.0151664. eCollection 2016.
8
Identification of missing variants by combining multiple analytic pipelines.通过结合多个分析管道识别缺失的变异。
BMC Bioinformatics. 2018 Apr 16;19(1):139. doi: 10.1186/s12859-018-2151-0.
9
Strategies for identification of somatic variants using the Ion Torrent deep targeted sequencing platform.使用 Ion Torrent 深度靶向测序平台鉴定体细胞变异的策略。
BMC Bioinformatics. 2018 Jan 4;19(1):5. doi: 10.1186/s12859-017-1991-3.
10
Structural variation detection using next-generation sequencing data: A comparative technical review.利用下一代测序数据进行结构变异检测:一项比较技术综述。
Methods. 2016 Jun 1;102:36-49. doi: 10.1016/j.ymeth.2016.01.020. Epub 2016 Feb 1.

引用本文的文献

1
Big Data to Knowledge: Application of Machine Learning to Predictive Modeling of Therapeutic Response in Cancer.从大数据到知识:机器学习在癌症治疗反应预测建模中的应用
Curr Genomics. 2021 Dec 16;22(4):244-266. doi: 10.2174/1389202921999201224110101.
2
Hardware acceleration of genomics data analysis: challenges and opportunities.基因组数据分析的硬件加速:挑战与机遇
Bioinformatics. 2021 Jul 27;37(13):1785-1795. doi: 10.1093/bioinformatics/btab017.
3
Next-generation sequencing for constitutional variants in the clinical laboratory, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG).

本文引用的文献

1
Best practices for benchmarking germline small-variant calls in human genomes.人类基因组中小变异calls 的基准测试最佳实践。
Nat Biotechnol. 2019 May;37(5):555-560. doi: 10.1038/s41587-019-0054-x. Epub 2019 Mar 11.
2
Genomic Features and Clinical Management of Patients with Hereditary Pancreatic Cancer Syndromes and Familial Pancreatic Cancer.遗传性胰腺癌综合征和家族性胰腺癌患者的基因组特征和临床管理。
Int J Mol Sci. 2019 Jan 29;20(3):561. doi: 10.3390/ijms20030561.
3
European recommendations and quality assurance for cytogenomic analysis of haematological neoplasms.
临床实验室染色体结构变异的新一代测序检测:2021 年修订版:美国医学遗传学与基因组学学会(ACMG)的技术标准。
Genet Med. 2021 Aug;23(8):1399-1415. doi: 10.1038/s41436-021-01139-4. Epub 2021 Apr 29.
4
Evaluating the molecular diagnostic yield of joint genotyping-based approach for detecting rare germline pathogenic and putative loss-of-function variants.评估基于联合基因分型的分子诊断方法对检测罕见胚系致病性和疑似功能丧失变异体的分子诊断产量。
Genet Med. 2021 May;23(5):918-926. doi: 10.1038/s41436-020-01074-w. Epub 2021 Feb 2.
5
Detection of Pathogenic Variants With Germline Genetic Testing Using Deep Learning vs Standard Methods in Patients With Prostate Cancer and Melanoma.使用深度学习与标准方法对前列腺癌和黑色素瘤患者进行种系基因检测以发现致病性变异体。
JAMA. 2020 Nov 17;324(19):1957-1969. doi: 10.1001/jama.2020.20457.
6
Investigating the importance of individual mitochondrial genotype in susceptibility to drug-induced toxicity.研究个体线粒体基因型在药物诱导毒性易感性中的重要性。
Biochem Soc Trans. 2020 Jun 30;48(3):787-797. doi: 10.1042/BST20190233.
7
Dual Deep Sequencing Improves the Accuracy of Low-Frequency Somatic Mutation Detection in Cancer Gene Panel Testing.双重深度测序提高癌症基因panel 检测中低频种系突变检测的准确性。
Int J Mol Sci. 2020 May 16;21(10):3530. doi: 10.3390/ijms21103530.
8
The Many Faces of Gene Regulation in Cancer: A Computational Oncogenomics Outlook.癌症中基因调控的多面性:计算肿瘤基因组学展望。
Genes (Basel). 2019 Oct 30;10(11):865. doi: 10.3390/genes10110865.
9
Operationalization of Next-Generation Sequencing and Decision Support for Precision Oncology.下一代测序技术的实施与精准肿瘤学的决策支持
JCO Clin Cancer Inform. 2019 Sep;3:1-12. doi: 10.1200/CCI.19.00089.
10
Value of Collaboration among Multi-Domain Experts in Analysis of High-Throughput Genomics Data.多领域专家在高通量基因组数据分析中的协作价值。
Cancer Res. 2019 Oct 15;79(20):5140-5145. doi: 10.1158/0008-5472.CAN-19-0769. Epub 2019 Jul 23.
欧洲血液系统肿瘤细胞遗传学分析的推荐意见和质量保证
Leukemia. 2019 Aug;33(8):1851-1867. doi: 10.1038/s41375-019-0378-z. Epub 2019 Jan 29.
4
Germline and Somatic Tumor Testing in Gynecologic Cancer Care.妇科癌症护理中的种系和体细胞肿瘤检测。
Obstet Gynecol Clin North Am. 2019 Mar;46(1):37-53. doi: 10.1016/j.ogc.2018.09.003.
5
A Universal Analysis Pipeline of Hybrid Capture-Based Targeted Sequencing Data with Unique Molecular Indexes (UMIs).一种基于杂交捕获的靶向测序数据与独特分子索引(UMIs)的通用分析流程。
Genomics Inform. 2018 Dec;16(4):e29. doi: 10.5808/GI.2018.16.4.e29. Epub 2018 Dec 28.
6
In silico error correction improves cfDNA mutation calling.计算错误校正提高 cfDNA 突变检测。
Bioinformatics. 2019 Jul 15;35(14):2380-2385. doi: 10.1093/bioinformatics/bty1004.
7
Pisces: an accurate and versatile variant caller for somatic and germline next-generation sequencing data.双鱼座:用于体细胞和种系下一代测序数据的准确且通用的变异调用程序。
Bioinformatics. 2019 May 1;35(9):1579-1581. doi: 10.1093/bioinformatics/bty849.
8
Accurate and Sensitive Analysis of Minimal Residual Disease in Acute Myeloid Leukemia Using Deep Sequencing of Single Nucleotide Variations.利用单核苷酸变异的深度测序技术对急性髓细胞白血病微小残留病进行准确和敏感的分析。
J Mol Diagn. 2019 Jan;21(1):149-162. doi: 10.1016/j.jmoldx.2018.08.004. Epub 2018 Sep 29.
9
Minimal residual disease negativity using deep sequencing is a major prognostic factor in multiple myeloma.深度测序检测微小残留病灶阴性是多发性骨髓瘤的一个主要预后因素。
Blood. 2018 Dec 6;132(23):2456-2464. doi: 10.1182/blood-2018-06-858613. Epub 2018 Sep 24.
10
New Molecular Technologies for Minimal Residual Disease Evaluation in B-Cell Lymphoid Malignancies.用于B细胞淋巴恶性肿瘤微小残留病评估的新分子技术
J Clin Med. 2018 Sep 18;7(9):288. doi: 10.3390/jcm7090288.